便携式灌注体模实现定量动态对比增强磁共振成像精准分层前列腺癌分级:一项初步研究
前瞻性研究纳入44例拟行多参数MRI前列腺检查的患者,将P4置于盆腔下方进行成像,25例患者在多参数MRI后22±18天行组织取样,共确认31个前列腺癌病灶。基于P4校正后,低、中、高级别肿瘤的Ktrans分别为0.109±0.026 min⁻¹、0.163±0.049 min⁻¹和0.356±0.156 min⁻¹,组间差异有统计学意义;Ktrans值0.14 min⁻¹检测临床显著前列腺癌的敏感度和特异度在校正后为88%和93%,校正前为86%。结论认为P4可减少定量DCE-MRI测量误差,提高前列腺癌分级分层的准确性。
要点
- P4校正后低、中、高级别前列腺癌的Ktrans分别为0.109±0.026、0.163±0.049、0.356±0.156 min⁻¹,组间差异有统计学意义。
- Ktrans阈值0.14 min⁻¹检测临床显著前列腺癌的敏感度88%、特异度93%(P4校正后),校正前特异度为86%。
- P4可减少定量DCE-MRI测量误差,提高前列腺癌分级分层的准确性。
核心结论
- P4允许减少定量动态对比增强磁共振成像测量中的误差,提高前列腺癌分级分层的准确性。
研究设计与样本
- 前瞻性临床研究,招募44例拟行多参数MRI前列腺检查的患者,所有参与者均在盆腔区域下方放置P4后进行成像。
- 25例患者在多参数MRI后22±18天(均值±标准差)行组织取样,组织学检查共确认31个前列腺癌病灶。
- 肿瘤分为低级别(n=14)、中级别(n=10)和高级别(n=7),比较P4校正前后低、中、高级别肿瘤的Ktrans。
诊断标准与关键数值
- P4校正后,低、中、高级别肿瘤的Ktrans分别为0.109±0.026 min⁻¹(95%CI:0.0094至0.124 min⁻¹)、0.163±0.049 min⁻¹(95%CI:0.129至0.198 min⁻¹)和0.356±0.156 min⁻¹(95%CI:0.215至0.495 min⁻¹),组间差异有统计学意义(低级别 vs 中级别:p=0.002;中级别 vs 高级别:p=0.002;低级别 vs 高级别:p<0.001)。
- P4校正后,Ktrans值0.14 min⁻¹检测临床显著前列腺癌的敏感度和特异度分别为88%和93%;校正前敏感度和特异度分别为88%和86%。
临床应用与阅片要点
- 作者认为,P4可减少定量动态对比增强磁共振成像测量误差,提高前列腺癌分级分层的准确性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The study goal was to test whether the improved accuracy in quantitative dynamic contrast-enhanced magnetic resonance imaging measurement using a point-of-care portable perfusion phantom (P4) leads to better stratification of prostate cancer grade.
MATERIALS AND METHODS: A prospective clinical study was conducted recruiting 44 patients scheduled for multi-parameter MRI prostate exams. All participants were imaged with the P4 placed under their pelvic regions. Tissue sampling was carried out for 25 patients at 22 ± 18 (mean ± SD) days after multi-parameter MRI. On histologic examination, a total of 31 lesions were confirmed as prostate cancer. Tumors were classified into low grade (n = 14), intermediate grade (n = 10), and high grade (n = 7). Tumor perfusion was assessed by volume transfer constant, Ktrans, before and after P4-based error correction, and the Ktrans of low, intermediate and high-grade tumors were statistically compared.
RESULTS: After P4-based error correction, the Ktrans of low, intermediate, and high-grade tumors were 0.109 ± 0.026 min-1 (95% CI: 0.0094 to 0.124 min-1), 0.163 ± 0.049 min-1 (95% CI: 0.129 to 0.198 min-1) and 0.356 ± 0.156 min-1 (95% CI: 0.215 to 0.495 min-1), respectively, with statistically significant difference among the groups (low vs intermediate: p = 0.002; intermediate vs high: p = 0.002; low vs high: p < 0.001). The sensitivity and specificity of Ktrans value, 0.14 min-1, to detect the clinically significant prostate cancer were 88% and 93%, respectively, after P4 based error correction, but those before error correction were 88% and 86%, respectively.
CONCLUSION: The P4 allows to reduce errors in quantitative dynamic contrast-enhanced magnetic resonance imaging measurement, enhancing accuracy in stratification of prostate cancer grade.
引用
- Kim H, Thomas JV, Nix JW, et al. Portable Perfusion Phantom Offers Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Accurate Prostate Cancer Grade Stratification: A Pilot Study. Acad Radiol. 2020. PMID: 32224036. doi:10.1016/j.acra.2020.02.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。